First Trust Advisors LP Sells 5,319 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

First Trust Advisors LP trimmed its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 51.1% in the fourth quarter, HoldingsChannel reports. The firm owned 5,100 shares of the company’s stock after selling 5,319 shares during the quarter. First Trust Advisors LP’s holdings in Acadia Healthcare were worth $202,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Lindbrook Capital LLC grew its position in Acadia Healthcare by 1,342.0% in the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company’s stock worth $29,000 after purchasing an additional 671 shares in the last quarter. Blue Trust Inc. grew its position in Acadia Healthcare by 69.4% in the 4th quarter. Blue Trust Inc. now owns 842 shares of the company’s stock worth $33,000 after purchasing an additional 345 shares in the last quarter. Nisa Investment Advisors LLC grew its position in Acadia Healthcare by 40.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock worth $41,000 after purchasing an additional 301 shares in the last quarter. Signaturefd LLC boosted its stake in Acadia Healthcare by 460.6% in the fourth quarter. Signaturefd LLC now owns 1,222 shares of the company’s stock valued at $48,000 after acquiring an additional 1,004 shares during the last quarter. Finally, Fifth Third Bancorp boosted its stake in Acadia Healthcare by 56.0% in the fourth quarter. Fifth Third Bancorp now owns 1,264 shares of the company’s stock valued at $50,000 after acquiring an additional 454 shares during the last quarter.

Wall Street Analyst Weigh In

A number of research firms have weighed in on ACHC. Bank of America dropped their target price on shares of Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating on the stock in a research note on Friday, February 28th. Royal Bank of Canada dropped their target price on shares of Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating on the stock in a research note on Monday, March 3rd. KeyCorp dropped their target price on shares of Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating on the stock in a research note on Monday, March 3rd. Mizuho dropped their target price on shares of Acadia Healthcare from $48.00 to $37.00 and set a “neutral” rating on the stock in a research note on Tuesday, March 25th. Finally, Barclays cut shares of Acadia Healthcare from an “overweight” rating to an “equal weight” rating and dropped their target price for the company from $43.00 to $35.00 in a research note on Friday, February 28th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $50.39.

Acadia Healthcare Stock Performance

Shares of ACHC stock opened at $23.87 on Monday. The stock has a market capitalization of $2.20 billion, a P/E ratio of 7.83, a PEG ratio of 1.46 and a beta of 1.01. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The firm’s 50 day moving average is $26.57 and its 200 day moving average is $36.32. Acadia Healthcare Company, Inc. has a 12 month low of $20.36 and a 12 month high of $82.41.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.